amgen horizon


FTC: Amgen-Horizon Deal Would Cement Monopoly for Treatment of Two Diseases

Commission pauses major biopharma transaction involving drugs priced in the hundreds of thousands of dollars. As part of the Federal Trade Commission’s promised campaign to…